A novel mutation of BEST1 gene in Best disease.


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 24 4 2020
medline: 20 8 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

To describe a new genetic variation of BEST1 gene in Best vitelliform macular dystrophy. A patient with bilateral multiple retinal yellowish lesions at the posterior pole underwent fluorescein angiography, fundus autofluorescence, optical coherence tomography, electrooculogram and blood sample for genetic testing. A diagnosis of a Best vitelliform macular dystrophy was made. Heterozygous mutation c.76G > A (p.Gly26Ser) in exon 2 of the BEST1 gene was found. These findings contribute to expand the mutation spectrum of BEST1 gene.

Identifiants

pubmed: 32321300
doi: 10.1177/1120672120920536
doi:

Substances chimiques

BEST1 protein, human 0
Bestrophins 0
Chloride Channels 0
Eye Proteins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

NP93-NP95

Auteurs

Claudio Campa (C)

Eye Clinic, Arcispedale Sant' Anna University Hospital, Ferrara, Italy.

Francesco Parmeggiani (F)

Eye Clinic, Arcispedale Sant' Anna University Hospital, Ferrara, Italy.

Rossella Spena (R)

Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Istituto internazionale per la Ricerca e Formazione in Oftalmologia (IRFO), Forlì, Italy.
Department of Ophthalmology, Ospedali Privati Forlì, Forlì, Italy.

Davide Ognibene (D)

UOL of Medical Genetics, Arcispedale Sant'Anna University Hospital and University of Ferrara, Ferrara, Italy.

Ilaria Passerini (I)

S.O.D. Diagnostica Genetica, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy.

Francesca Gualandi (F)

UOL of Medical Genetics, Arcispedale Sant'Anna University Hospital and University of Ferrara, Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH